Cannabidiol for people with schizophrenia

Diana Buitrago-Garcia; Guillermo Sanchez Vanegas; Paula Alejandra Sánchez Correa; Stela del pilar Baracaldo; Santiago Felipe Gallego Gallego; Lone Baandrup

doi:10.1002/14651858.CD014602

Cannabidiol for people with schizophrenia

Diana Buitrago-Garcia
, Guillermo Sanchez Vanegas
, Paula Alejandra Sánchez Correa
, Stela del pilar Baracaldo
, Santiago Felipe Gallego Gallego
, Lone Baandrup

School of Medicine and Health Sciences

Research output: Contribution to Journal › Research Article › peer-review

Abstract

Objectives:

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the effectiveness and safety of CBD in the treatment of people with schizophrenia.

Translated title of the contribution	Cannabidiol para personas con esquizofrenia
Original language	English (US)
Journal	Cochrane Database of Systematic Reviews
DOIs	https://doi.org/10.1002/14651858.CD014602
State	Published - Nov 16 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Psychiatry and Mental health

Access to Document

10.1002/14651858.CD014602

Cite this

@article{66071a2f5ca647319204551c2003ef7c,

title = "Cannabidiol for people with schizophrenia",

abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effectiveness and safety of CBD in the treatment of people with schizophrenia.",

author = "Diana Buitrago-Garcia and \{Sanchez Vanegas\}, Guillermo and \{S{\'a}nchez Correa\}, \{Paula Alejandra\} and Baracaldo, \{Stela del pilar\} and \{Gallego Gallego\}, \{Santiago Felipe\} and Lone Baandrup",

year = "2020",

month = nov,

day = "16",

doi = "10.1002/14651858.CD014602",

language = "English (US)",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Cannabidiol for people with schizophrenia

AU - Buitrago-Garcia, Diana

AU - Sanchez Vanegas, Guillermo

AU - Sánchez Correa, Paula Alejandra

AU - Baracaldo, Stela del pilar

AU - Gallego Gallego, Santiago Felipe

AU - Baandrup, Lone

PY - 2020/11/16

Y1 - 2020/11/16

N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effectiveness and safety of CBD in the treatment of people with schizophrenia.

AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effectiveness and safety of CBD in the treatment of people with schizophrenia.

U2 - 10.1002/14651858.CD014602

DO - 10.1002/14651858.CD014602

M3 - Research Article

SN - 1465-1858

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

ER -

Cannabidiol for people with schizophrenia

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Fingerprint

Cite this